N-[4-(3,6-Diamino-acridin-9-ylamino)-phenyl]-methanesulfonamide

ID: ALA37647

Cas Number: 76015-35-5

PubChem CID: 127111

Max Phase: Preclinical

Molecular Formula: C20H19N5O2S

Molecular Weight: 393.47

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)Nc1ccc(Nc2c3ccc(N)cc3nc3cc(N)ccc23)cc1

Standard InChI:  InChI=1S/C20H19N5O2S/c1-28(26,27)25-15-6-4-14(5-7-15)23-20-16-8-2-12(21)10-18(16)24-19-11-13(22)3-9-17(19)20/h2-11,25H,21-22H2,1H3,(H,23,24)

Standard InChI Key:  DFPFHWONJWGBDW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -2.2595   -9.5528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2606  -10.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5459  -10.7929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5477   -9.1401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8324   -9.5492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8317  -10.3759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1165  -10.7868    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1221   -9.1350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5937   -9.5423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5973  -10.3718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3163  -10.7815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0322  -10.3630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0246   -9.5304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3050   -9.1243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7496  -10.7702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1265   -8.3102    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5857   -7.8940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2976   -8.3060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0093   -7.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0054   -7.0647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2838   -6.6563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5751   -7.0742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9753  -10.7919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7170   -6.6476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4341   -7.0552    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.1452   -7.4657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8442   -6.3395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0275   -7.7729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  6  2  0
 13 14  2  0
 14  9  1  0
  6  7  1  0
 12 15  1  0
  7 10  2  0
  8 16  1  0
  1  2  2  0
 16 17  1  0
  9  8  2  0
 17 18  2  0
  8  5  1  0
 18 19  1  0
  5  4  2  0
 19 20  2  0
  4  1  1  0
 20 21  1  0
  9 10  1  0
 21 22  2  0
 22 17  1  0
  2 23  1  0
 10 11  1  0
 20 24  1  0
  2  3  1  0
 24 25  1  0
 11 12  2  0
 25 26  1  0
  5  6  1  0
 25 27  2  0
 12 13  1  0
 25 28  2  0
M  END

Associated Targets(Human)

Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II (1334 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2 DNA topoisomerase 2 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus sp. (1192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.47Molecular Weight (Monoisotopic): 393.1259AlogP: 3.67#Rotatable Bonds: 4
Polar Surface Area: 123.13Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.43CX Basic pKa: 10.30CX LogP: 1.45CX LogD: -0.01
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.31Np Likeness Score: -0.87

References

1. Gamage SA, Tepsiri N, Wilairat P, Wojcik SJ, Figgitt DP, Ralph RK, Denny WA..  (1994)  Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum.,  37  (10): [PMID:8182707] [10.1021/jm00036a014]
2. Denny WA, Cain BF, Atwell GJ, Hansch C, Panthananickal A, Leo A..  (1982)  Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents.,  25  (3): [PMID:7069706] [10.1021/jm00345a015]
3. Acharya BN, Saraswat D, Kaushik MP..  (2008)  Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway.,  43  (12): [PMID:18395298] [10.1016/j.ejmech.2008.02.005]
4. Prado-Prado FJ, García-Mera X, González-Díaz H..  (2010)  Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.,  18  (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068]

Source